Cancer detection during the COVID‐19 pandemic—Experiences in primary care and recommendations for the future

BACKGROUND: To describe general practitioners (GPs) experiences with the impact COVID‐19 on the duration of cancer detection. METHODS: Cross‐sectional survey study among Dutch GPs. RESULTS: Fifty‐eight GPs participated. During the first wave, COVID‐19‐related delays were experienced by 88%, 52%, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Siepman Van den Berg, Marinde F. R., Grant, Matthew, van Erp, Nicole, van Gils, Carla H., Muris, Jean, Brandenbarg, Daan, van Asselt, Kristel M., de Wit, Niek J., Helsper, Charles W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Preliminary Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877740/
https://www.ncbi.nlm.nih.gov/pubmed/36718286
http://dx.doi.org/10.1002/jgf2.597
Descripción
Sumario:BACKGROUND: To describe general practitioners (GPs) experiences with the impact COVID‐19 on the duration of cancer detection. METHODS: Cross‐sectional survey study among Dutch GPs. RESULTS: Fifty‐eight GPs participated. During the first wave, COVID‐19‐related delays were experienced by 88%, 52%, and 67% of GPs in the contact‐seeking, primary care, and referral phases, respectively. GPs reported delays due to telehealth consultations, longer waiting times and patient's concerns of COVID infections and overburdening GPs. CONCLUSIONS: The majority of GPs experienced delays in cancer diagnostic processes during the beginning of the COVID pandemic, which was most prominent in the timeliness in which patients sought GP care.

Ejemplares similares